01
Overview
BioCen is a Cuban biopharmaceutical company with commercial manufacturing of active pharmaceutical ingredients such as Granulocyte Colony Stimulating Factor and Recombinant Streptokinase. It also develops immunomodulators, allergenic vaccines, antianemics, food supplements/nutraceuticals, microbiological and plant culture media, and products for Alzheimer’s disease. The company operates under ISO 9001-certified quality management systems and offers contract manufacturing services to other companies. Its facilities are GMP-compliant and certified by Cuban/foreign regulatory authorities
- Therapeutic areas
- OncologyImmunologyHematologyCardiovascularNeurology
- Modalities
- Recombinant proteinSmall moleculeVaccineNutraceuticals
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
not explicitly listed; provides contract manufacturing services to other companies
Beyond the preview
Go deeper on BioCen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioCen.